Mantovani A
That trial would help determine the optimal dose to advance into larger late-stage studies required for regulatory approval
Mechanisms of action and therapeutic application of glucagon-like peptide-1
Furthermore, this approach, creating a multispecific that is bivalent to the target and monovalent to the effector cell, results in a molecule with a mass similar to that of other multispecific antibodies that are already FDA-approved (e.g., Glofitamab) or still being evaluated in clinical trials (e.g., Imvotamab, an IgM-based bispecific)
*Malabsorption describes a diminished capacity for the body to sufficiently absorb and/or digest fat, protein, carbohydrate, and other nutrients from the diet to meet nutritional needs
A bottle of red wine commonly has about 7 and a half to 8 standard drinks per bottle